Vaginal Discharge And STD

More documents

Recommendations

Info

• Recurrent disease BV – 30 % of women will develop recurrence – Women with more than 3 episodes in one year • Suppressive therapy with metro gel 2x/wk x 6 Suppressive therapy with metro gel 2x/wk x 6 months
Trichomonas Trichomonas <strong>Vaginal</strong>is • Infection with protozoan trichomonas vaginalis • Accounts for anywhere b/w 44-35% 35% of cases of vaginitis • SSexually ll ttransmitted itt d
Page 1 and 2: Vaginal Discharge Discharge and STD
Page 3 and 4: Epidemiology • Lifetime risk for
Page 5 and 6: • Dx: Vulvovaginal Candidiasis -
Page 7 and 8: Treatment • Uncomplicated infecti
Page 9 and 10: Bacterial Vaginosis • Replacement
Page 11 and 12: • Diagnosis g - Hx and PE: BV •
Page 13: • Treatment BV - Metronidazole 50
Page 17 and 18: • Diagnosis Trichomonas Trichomon
Page 19 and 20: • Treatment - Metronidazole Trich
Page 21 and 22: Atrophic Vaginitis • Dryness and
Page 23 and 24: • Clinical - History - Pelvic exa
Page 25 and 26: Chlamydia • Chlamydia trachomatis
Page 27 and 28: • Diagnosis Chlamydia - Nucleic a
Page 29 and 30: N. Gonorrhea Gonorrhea • Clinical
Page 31 and 32: N. Gonorrhea Gonorrhea • Treatmen
Page 33 and 34: Pelvic Pelvic Inflammatory Disease
Page 35 and 36: Pelvic Pelvic Inflammatory Disease
Page 37 and 38: • Treatment - Outpatient PID •
Page 39: Anogenital HPV • Single or multip
Page 42 and 43: • Home treatment Imiquimod Imiqui
Page 44 and 45: • TCA Trichloroacetic Trichloroac
Page 46 and 47: Clinical Clinical Manifestations
Page 48 and 49: Herpes
Page 50 and 51: Treatment • Primary y infection -
Page 52 and 53: Syphilis • Sexually y transmitted
Page 54 and 55: Chancre
Page 56 and 57: Latent Latent Syphilis • Asymptom
Page 58 and 59: • Asymptomatic • Symptomatic Ne
Page 60 and 61: Treatment • Primary, y, secondary
Page 62 and 63: Screening Guidelines • Screen for
Page 64:
Screening Continued • HIV screeni
show all

Vaginal Discharge And STD

Create successful ePaper yourself

Delete template?

Save as template?